Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Daiichi Sankyo Submits Edoxaban NDA

April 9, 2010 6:13 am | News | Comments

Daiichi Sankyo Company, Limited announced that it has submitted a New Drug Application to in Japan seeking approval of the anticoagulant, edoxaban, for the prevention of venous thromboembolism (VTE) after major orthopedic surgery.


Peptide Allows Deeper Tumor Penetration

April 9, 2010 6:07 am | News | Comments

Researchers have shown that a peptide called iRGD helps co-administered drugs penetrate deeply into tumor tissue. The peptide has been shown to substantially increase treatment efficacy against human breast, prostate, and pancreatic cancers in mice.


Autism Study Finds Possible Drug Target

April 9, 2010 6:03 am | News | Comments

A new discovery raises hope that autism may be more easily diagnosed and that its effects may be more reversible than previously thought.


New Method Allows Scientists To Probe Gene Activation

April 9, 2010 5:59 am | News | Comments

NYU Langone Medical Center researchers have developed a powerful new method to investigate the discrete steps necessary to turn on individual genes and examine how the process goes wrong in cancer and other diseases.


Hepatitis C Doubles Risk of Kidney Cancer

April 9, 2010 5:54 am | News | Comments

Physicians found that from 1997-2008, 0.6% of patients with hepatitis C infection developed kidney cancer whereas only 0.3% patients without the disease developed kidney cancer.


Nanoparticle Vaccine Cures Type 1 Diabetes

April 9, 2010 5:51 am | News | Comments

Using a sophisticated nanotechnology-based "vaccine," researchers were able to successfully cure mice with type 1 diabetes and slow the onset of the disease in mice at risk for the disease.


Compound Destroys Antibiotic-Resistant Biofilms

April 9, 2010 5:46 am | News | Comments

Researchers at North Carolina State University have found a chemical compound that, when used in conjunction with conventional antibiotics, is effective in destroying biofilms produced by antibiotic-resistant strains of bacteria such as the Staphylococcus strain MRSA.


Sanofi And CureDM to Develop Diabetes Treatment

April 9, 2010 5:41 am | News | Comments

Sanofi-Aventis and CureDM Group Holdings LLC will work to develop a diabetes treatment aimed at restoring a patient's ability to produce insulin and other pancreatic hormones.


FDA Reviewing Triclosan Usage

April 9, 2010 5:37 am | News | Comments

The Food and Drug Administration is reviewing the safety of a widely used chemical found in antibacterial soap, toothpaste and other consumer goods.


LC/MS Solvents

April 8, 2010 6:25 am | Product Releases | Comments

Mallinckrodt Baker’s J.T.Baker ULTRA Liquid Chromatography/Mass Spectrometry solvents are designed for the most demanding ultra-high pressure liquid chromatography and mass spectrometry research and analytical testing applications.


Microscope Automation System

April 8, 2010 6:09 am | Product Releases | Comments

Prior Scientific introduces a significant advancement in microscope automation control - the ProScan III Microscope Automation System.


Chromatography Data System

April 8, 2010 6:03 am | Product Releases | Comments

Thermo Fisher Scientific Inc. announced the availability of a Thermo Scientific Atlas Chromatography Data System integration solution for Symyx Technologies' electronic laboratory notebook.


Mallinckrodt Baker Introduces New Grade of Acetonitrile

April 8, 2010 5:58 am | News | Comments

Mallinckrodt Baker, a business unit of Covidien, a global provider of healthcare products, has introduced a new grade of acetonitrile to match the quality requirements for customers performing routine high-performance liquid chromatography applications and analysis.


ISICR Accepting Nominees for Milstein Prize

April 8, 2010 5:53 am | News | Comments

At the Annual Meeting of the International Society of Interferon and Cytokine Research, the Milstein Prize will be bestowed upon a leading biomedical research scientist who has made outstanding contributions to research related to interferons and cytokines.


Sumatriptan Performs Well in Phase 2 Trial

April 8, 2010 5:45 am | News | Comments

OptiNose, a maker of nasal drug delivery systems, has announced the publication in Cephalalgia of results from its Phase 2 clinical study investigating the efficacy and tolerability of its novel, intranasal drug/device product for the treatment of migraine.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.